Literature DB >> 31776854

LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.

Junfeng Yu1, Zhejian Ou1, Yangyang Lei2, Liuhua Chen1, Qiao Su3, Kunsong Zhang4.   

Abstract

Hepatocellular carcinoma (HCC) remains one of the most common and aggressive human cancers worldwide. Accumulating evidences indicate that non-coding RNAs are critical regulators implicated in various physiological processes including HCC development. Long non-coding RNA (lncRNA) MYCN opposite-strand (MYCNOS) was reported to be up-regulated in several human cancers, yet its role in HCC progression is still elusive. In the present study, MYCNOS was up-regulated in both HCC tissues and cell lines, and elevated MYCNOS expression was correlated to shorter survival time of HCC patients. We knocked down MYCNOS expression using short hairpin RNAs specifically targeting MYCNOS. MYCNOS knockdown significantly inhibited proliferation in HCC cells in vitro accompanied by exacerbated cell apoptosis; it also suppressed tumor growth in mouse model in vivo. Besides, the migration and invasion of HCC cells were remarkably inhibited after MYCNOS knockdown. In addition, MYCNOS acted as a negative regulator of miR-340 in HCC cells, and all effects of MYCNOS knockdown were abrogated by further miR-340 inhibition. We also discovered that oncogene phosphatidylinositol-3, 4, 5-trisphosphate-dependent Rac exchange factor 2 (PREX2) was a downstream target of miR-340, and PREX2 expression was positively correlated to that of MYCNOS in HCC tissues. In conclusion, our findings demonstrated that MYCNOS knockdown inhibited HCC progression through regulating miR-340.

Entities:  

Keywords:  Hepatocellular carcinoma; MYCNOS; MiR-340; PREX2; Proliferation/invasion

Mesh:

Substances:

Year:  2019        PMID: 31776854     DOI: 10.1007/s13577-019-00303-y

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  27 in total

Review 1.  Long non-coding RNAs: a new frontier in the study of human diseases.

Authors:  Xuefei Shi; Ming Sun; Hongbing Liu; Yanwen Yao; Yong Song
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

Review 2.  Long noncoding RNAs: functional surprises from the RNA world.

Authors:  Jeremy E Wilusz; Hongjae Sunwoo; David L Spector
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

Review 3.  Long noncoding RNAs and human disease.

Authors:  Orly Wapinski; Howard Y Chang
Journal:  Trends Cell Biol       Date:  2011-05-06       Impact factor: 20.808

4.  miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.

Authors:  Zheng-sheng Wu; Qiang Wu; Chao-qun Wang; Xiao-nan Wang; Jing Huang; Jing-jing Zhao; Shan-shan Mao; Gui-hong Zhang; Xiao-chun Xu; Nong Zhang
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

5.  Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Kiichiro Hashimoto; Akira Tangoku; Kenji Hamada; Hironobu Nakayama; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Oncogene       Date:  2003-05-15       Impact factor: 9.867

Review 6.  Long noncoding RNA: an emerging paradigm of cancer research.

Authors:  Man-Tang Qiu; Jing-Wen Hu; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2013-01-29

7.  MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.

Authors:  Xin Zhou; Min Wei; Wei Wang
Journal:  Biochem Biophys Res Commun       Date:  2013-07-18       Impact factor: 3.575

Review 8.  Long noncoding RNA in prostate, bladder, and kidney cancer.

Authors:  Elena S Martens-Uzunova; René Böttcher; Carlo M Croce; Guido Jenster; Tapio Visakorpi; George A Calin
Journal:  Eur Urol       Date:  2013-12-14       Impact factor: 20.096

9.  miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.

Authors:  S Fernandez; M Risolino; N Mandia; F Talotta; Y Soini; M Incoronato; G Condorelli; S Banfi; P Verde
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

10.  The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.

Authors:  Eleanor M O'Brien; Joanna L Selfe; Ana Sofia Martins; Zoë S Walters; Janet M Shipley
Journal:  BMC Cancer       Date:  2018-02-21       Impact factor: 4.430

View more
  4 in total

1.  Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis.

Authors:  Wei Liang; Jinyuan Ke
Journal:  Int J Exp Pathol       Date:  2022-02-13       Impact factor: 1.925

2.  LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.

Authors:  Dan Liu; Yue Wan; Ning Qu; Qiang Fu; Chao Liang; Lingda Zeng; Yang Yang
Journal:  Front Public Health       Date:  2022-07-06

3.  Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.

Authors:  Duangporn Saengwimol; Pamorn Chittavanich; Natanan Laosillapacharoen; Atthapol Srimongkol; Vijender Chaitankar; Duangnate Rojanaporn; Rangsima Aroonroch; Bhoom Suktitipat; Chonticha Saisawang; Saovaros Svasti; Suradej Hongeng; Rossukon Kaewkhaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

Review 4.  The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Bashdar Mahmud Hussen; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.